Relevance of Network Hierarchy in Cancer Drug-Target Selection

Aritro Nath, Christina Chan

Research output: Chapter in Book/Report/Conference proceedingChapter

  • 1 Citations

Abstract

Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.

LanguageEnglish (US)
Title of host publicationSystems Biology in Cancer Research and Drug Discovery
PublisherSpringer Netherlands
Pages339-362
Number of pages24
ISBN (Print)9789400748194, 9400748183, 9789400748187
DOIs
StatePublished - Aug 1 2013

Profile

Pharmaceutical Preparations
Neoplasms
Neoplasm Genes
Prostatic Neoplasms
Therapeutics

Keywords

  • Boolean modeling
  • Hierarchical network
  • Prostate cancer
  • Targeted therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nath, A., & Chan, C. (2013). Relevance of Network Hierarchy in Cancer Drug-Target Selection. In Systems Biology in Cancer Research and Drug Discovery (pp. 339-362). Springer Netherlands. DOI: 10.1007/978-94-007-4819-4_15

Relevance of Network Hierarchy in Cancer Drug-Target Selection. / Nath, Aritro; Chan, Christina.

Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands, 2013. p. 339-362.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nath, A & Chan, C 2013, Relevance of Network Hierarchy in Cancer Drug-Target Selection. in Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands, pp. 339-362. DOI: 10.1007/978-94-007-4819-4_15
Nath A, Chan C. Relevance of Network Hierarchy in Cancer Drug-Target Selection. In Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands. 2013. p. 339-362. Available from, DOI: 10.1007/978-94-007-4819-4_15
Nath, Aritro ; Chan, Christina. / Relevance of Network Hierarchy in Cancer Drug-Target Selection. Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands, 2013. pp. 339-362
@inbook{fe14da784d584e3b93ec3f6a8299b7c2,
title = "Relevance of Network Hierarchy in Cancer Drug-Target Selection",
abstract = "Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.",
keywords = "Boolean modeling, Hierarchical network, Prostate cancer, Targeted therapy",
author = "Aritro Nath and Christina Chan",
year = "2013",
month = "8",
day = "1",
doi = "10.1007/978-94-007-4819-4_15",
language = "English (US)",
isbn = "9789400748194",
pages = "339--362",
booktitle = "Systems Biology in Cancer Research and Drug Discovery",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Relevance of Network Hierarchy in Cancer Drug-Target Selection

AU - Nath,Aritro

AU - Chan,Christina

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.

AB - Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.

KW - Boolean modeling

KW - Hierarchical network

KW - Prostate cancer

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84933533032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933533032&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-4819-4_15

DO - 10.1007/978-94-007-4819-4_15

M3 - Chapter

SN - 9789400748194

SN - 9400748183

SN - 9789400748187

SP - 339

EP - 362

BT - Systems Biology in Cancer Research and Drug Discovery

PB - Springer Netherlands

ER -